Top 10 Trending Stocks for 07/30: Twitter (TWTR), Amgen (AMGN), Regeneron (REGN), and More... Jul 30, 2014 10:29AM
Pre-Open Stock Movers 7/30: (GFIG) (TWTR) (NQ) Higher; (NTRI) (BWLD) (DWA) Lower (more...) Jul 30, 2014 09:32AM
After-Hours Stock Movers 7/29: (TWTR) (ZLTQ) (X) Higher; (NTRI) (BWLD) (DWA) Lower (more...) Jul 29, 2014 06:10PM
Market Wrap: Home Prices Gain at Slower Pace; Twitter Soars in Q2; Ford Opts for Apple Jul 29, 2014 05:37PM
Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 Jul 29, 2014 04:37PM


Jul 28, 2014 05:11PM Trading Radar for 07/29: Pfizer (PFE), Marriott (MAR), UPS (UPS), Anadarko (APC), Ballard Power (BLDP) Report
Jul 25, 2014 04:00PM Amgen Announces 2014 Third Quarter Dividend
Jul 25, 2014 02:30AM Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer
Jul 24, 2014 04:00PM Amgen Announces Webcast of 2014 Second Quarter Financial Results
Jul 17, 2014 04:01PM Amgen Announces Positive Phase 3 Results for AMG 416 for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Receiving Hemodialysis
Jul 1, 2014 08:09AM Amgen Receives FDA Breakthrough Therapy Designation For Investigational BiTE® Antibody Blinatumomab In Acute Lymphoblastic Leukemia
Jun 16, 2014 04:03PM Amgen Joins The National Cancer Institute And Research Partners To Help Accelerate Development Of Personalized Treatment Approaches For Squamous Cell Lung Cancer
Jun 11, 2014 05:00PM Brodalumab Treatment Improved Clinical Signs And Symptoms In Phase 2 Psoriatic Arthritis Study Published In The New England Journal Of Medicine
Jun 9, 2014 04:15PM Amgen Appoints David W. Meline Executive Vice President and Chief Financial Officer
Jun 6, 2014 04:15PM Amgen To Present At The Goldman Sachs Global Healthcare Conference
Jun 2, 2014 07:44AM Amgen Presents New Data On Talimogene Laherparepvec As Single Agent And Combination Therapy In Metastatic Melanoma At ASCO
Jun 1, 2014 10:11AM New Detailed Phase 3 Data Show Amgen's Novel Investigational Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With A Rare And Serious Genetic Disorder That
May 31, 2014 08:00AM Amgen Highlights Phase 2 Results Of Vectibix® (panitumumab) Versus bevacizumab In Combination With FOLFOX In Patients With Wild-Type RAS (KRAS And NRAS) Metastatic Colorectal Cancer
May 30, 2014 04:58PM Amgen To Present At The Jefferies 2014 Global Healthcare Conference
May 29, 2014 05:39PM Amgen To Host Post-American Society of Clinical Oncology (ASCO) Summary Webcast
May 27, 2014 04:01PM Amgen and Onyx Data at ASCO 2014 Highlight Oncology Pipeline and Portfolio
May 23, 2014 05:11PM FDA Approves First-Line Use of Vectibix® (Panitumumab) Plus FOLFOX for Patients with Wild-Type KRAS Metastatic Colorectal Cancer
May 20, 2014 04:01PM The New England Journal Of Medicine Publishes Positive Proof-Of-Concept Data For New Asthma Treatment
May 15, 2014 04:42PM Amgen Announces Voting Results of Annual Meeting of Stockholders
May 13, 2014 04:17PM Journal Of The American Medical Association Publishes Phase 3 LAPLACE-2 Study Showing Evolocumab Significantly Reduced LDL Cholesterol In Patients On Statins Regardless Of Statin Dose
May 12, 2014 04:38PM Amgen's Breakaway from Cancer® Honors Four California Cancer Survivors During The Ninth Annual Amgen Tour of California
May 12, 2014 04:03PM Amgen Names Steven K. Galson, Senior Vice President, Global Regulatory Affairs And Safety
May 9, 2014 04:01PM Amgen And AstraZeneca Announce Positive Results From Phase 3 Study Of Brodalumab (AMG 827) In Patients With Moderate-to-Severe Plaque Psoriasis
May 2, 2014 04:18PM Amgen To Present At The Deutsche Bank 39th Annual Healthcare Conference